Tracking Quality of Life During Prostate Cancer Treatment
Patients with advanced prostate cancer who received more intensive treatment experienced worse quality of life three months after treatment, but... Read More
Metastasizing Cancer Cells Modify Bone Remodeling with Small RNA Secretion
Prostate cancer is one of the most common cancers in men worldwide. In nearly three out of four patients, the... Read More
Research Identifies Cells That May be Responsible for Prostate Cancer Recurrence
Although men with prostate cancer usually respond to standard treatment with hormone therapy or chemotherapy, many will eventually experience progression... Read More
Researchers Zero in on Molecular Fingerprint for Prostate Cancer
“Cancer Biomarkers in Australia” by the Sansom Institute for Health Research at the University of South Australia (UniSA) found that the... Read More
Low Testosterone Levels Linked to Reduced Risk of Prostate Cancer
Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer, according... Read More
Promising New Prostate Cancer Test Developed
An easy to produce prostate cancer tracer, a substance vital for the discovery of cancers, has been developed by King’s... Read More
Availability of Robotic Prostate Cancer Surgery Could be a Bigger Draw for Patients Than Quality of Hospital
Prostate cancer patients in England may base their choice of hospital for surgery on the availability of new technology, rather... Read More
Software Helps Men with Prostate Cancer Choose the Right Treatments
The options men have after a diagnosis have different side effects and trade-offs. So choosing, for example, between radiation therapy... Read More
Software Helps Men with Prostate Cancer Choose the Right Treatments
Like many men diagnosed with prostate cancer, Bill Pickett faced a tough question when he came to UCLA for treatment:... Read More
Vascular Targeted Photodynamic Tx Aids Low-Risk Prostate Cancer
For men with low-risk prostate cancer, vascular targeted photodynamic therapy achieves an 82 percent rate of absent clinically significant cancer... Read More